Blackburn C, Barrett C, Brunson M, et al. Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform. Bioorg Med Chem Lett. 2014;24(23):5450–5454.
Besche HC, Sha Z, Kukushkin NV, et al. Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. EMBO J. 2014;33(10):1159–1176.
Gallery M, Blank JL, Lin Y, et al. The JAMM motif of human deubiquitinase Poh1 is essential for cell viability. Mol Cancer Ther. 2007;6(1):262–268.
Juan Gutierrez is a research scientist II under the direction of Anna Greka in the Therapeutics Projects Group of the Center for the Science of Therapeutics (CSofT) at the Broad Institute of MIT and Harvard. His focus is working on the discovery of therapeutics in kidney diseases via cellular assay and model development in support of high-content imaging screening, hit characterization, and small molecule medicinal chemistry programs.
Prior to joining the Broad Institute, Gutierrez worked at Takeda-Millennium Pharmaceuticals in anti-infectives (Helicobacter pylori and antifungals) and oncology drug discovery focused on protein homeostasis. His postdoctoral fellowship at the University of Florida in the lab of Dr. Arnold Bleiweis targeted mutagenesis and gene characterization in streptococci.
Gutierrez earned his doctorate in biology/biochemistry from Purdue University after obtaining a B.S. in biology and B.A. in chemistry from St. Louis University, St. Louis, Missouri.
Contact Juan Gutierrez via email at email@example.com.